Antidote use in the critically ill poisoned patient (Q34562529)

3 August 2017

1 reference

title

Antidote use in the critically ill poisoned patient (English)

1 reference

3 August 2017

1 reference

David P Betten

1

1 reference

3 August 2017

Rais B Vohra

2

1 reference

3 August 2017

Matthew D Cook

3

1 reference

3 August 2017

Michael J Matteucci

4

1 reference

3 August 2017

Richard F Clark

5

1 reference

3 August 2017

1 September 2006

1 reference

Journal of Intensive Care Medicine

3 August 2017

1 reference

3 August 2017

21

1 reference

3 August 2017

5

1 reference

3 August 2017

255-277

1 reference

Analeptic use in clinical toxicology: a historical appraisal

3 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Insufficient stocking of poisoning antidotes in hospital pharmacies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Unanswered questions in metal chelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Are we ready to replace dimercaprol (BAL) as an arsenic antidote?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The use of chelating agents in occupational lead poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A 20-hour treatment for acute acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fomepizole for the treatment of methanol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Treatment of methanol and isopropanol poisoning with intravenous fomepizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fomepizole in treatment of uncomplicated ethylene glycol poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Antidotes for methanol and ethylene glycol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Prevalence of autonomic signs and symptoms in antimuscarinic drug poisonings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Assessing physostigmine's contraindication in cyclic antidepressant ingestions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Asystole complicating physostigmine treatment of tricyclic antidepressant overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Potentiation of Tricyclic Antidepressant Toxicity by Physostigmine in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The Use of Physostigmine as an Antidote in Tricyclic Anti-depressant Intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Complications of diagnostic physostigmine administration to emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Patterns of presentation in heroin overdose resulting in pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A comprehensive review of naloxone for the emergency physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A dosing nomogram for continuous infusion intravenous naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

21 January 2018

Acute heroin overdose

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Acute overdosage with benzodiazepine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

First Clinical Investigation of the Benzodiazepine Antagonist Ro 15-1788 in Comatose Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fibreoptic intubation and bronchofibrescopy in anaesthesia and intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Reversal of benzodiazepine-induced sedation by intravenous Ro 15-1788.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The use of flumazenil in the management of acute drug poisoning — a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Flumazenil in mixed benzodiazepine/tricyclic antidepressant overdose: a placebo-controlled study in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Experimental amitriptyline intoxication: treatment of cardiac toxicity with sodium bicarbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

High K+ rapidly stimulates Ca2+-dependent phosphorylation of three proteins concomitant with insulin secretion from HIT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Prospective multicenter study of sulfonylurea ingestion in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Hypoglycemia following a nateglinide overdose in a suicide attempt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Octreotide: an antidote for sulfonylurea-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Pyridoxine in clinical toxicology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Convulsions as the etiology of lactic acidosis in acute isoniazid toxicity in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Evaluation of diazepam and pyridoxine as antidotes to isoniazid intoxication in rats and dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Clinical toxicology of cyanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Recent perspectives on the toxicodynamic basis of cyanide antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Cyanide toxicity from sodium nitroprusside: risks and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Hydroxycobalamin/sodium thiosulfate as a cyanide antidote

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Cyanide poisoning treated with hyperbaric oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Organophosphate poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Therapy for nerve agent poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Diazepam in the treatment of organophosphorus ester pesticide poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Comparative evaluation of benzodiazepines for control of soman-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

CNS involvement in acute organophosphate poisoning: specific pattern of toxicity, clinical correlates and antidotal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Nerve agent attacks on children: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Acute chemical emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The role of oximes in the management of organophosphorus pesticide poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Cellular electrophysiology of digitalis toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Plants and cardiac glycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Fab antibody fragments: some applications in clinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Oleander poisoning: Treatment with digoxin-specific fab antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Review of clinical experience with digoxin immune Fab (ovine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Glucagon in β‐Blocker and Calcium Channel Blocker Overdoses: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Management of calcium channel antagonist overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Treatment of calcium-channel-blocker intoxication with insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Absorption of iron after experimental overdose of chewable vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

An ovine model of maternal iron poisoning in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Intentional iron overdose in pregnancy--management and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Molecular and cellular biology of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

The mechanism of action of vitamin K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Clinically significant drug interactions with the oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Low-Dose Vitamin K Therapy in Excessively Anticoagulated Patients: A Dose-Finding Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Plasma disposition of vitamin K1 in relation to anticoagulant poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Managing oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

A prospective study of acute, unintentional, pediatric superwarfarin ingestions managed without decontamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

21 January 2018

Management of botulism

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Methemoglobinemia: etiology, pharmacology, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Acute Dapsone Intoxication: A Case with Prolonged Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Heinz body hemolytic anemia from the use of methylene blue in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Deaths resulting from animal attacks in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

21 January 2018

Reptile envenomations

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Skin testing in cases of possible crotalid envenomation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

Selective antagonists of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066606290386

21 January 2018

Identifiers

DOI

10.1177/0885066606290386

1 reference

3 August 2017

1 reference